In Vitro Diagnostics (IVD) Market

by segmented(instruments, reagents, and services & software),By End user(hospitals, standalone laboratory, academics & medical schools, point of care and others)-Global Industry opportunity,Analysis,Forecast 2016-2025

  • Date Diagnostics and Biotech
  • Date December 2016
  • price $3619
 
 

In Vitro Diagnostics Market- A Global Strategic IVD Industry Report 2025

The global in vitro diagnostics market has the potential to garner around $91.3 billion by 2025, registering a CAGR of 4.5% from 2017 to 2025. North American region will be the largest regional market during the forecast period. In vitro diagnostics (IVD) is a technique that involves use of medical reagents and devices to examine samples of tissues, urine, stool, blood, and other body fluids for determination of diseases and infections.

The tests are conducted in hospital based laboratory, stand-alone laboratory, and point of care testing centers. Microarray techniques, mass spectrometry, polymerase chain reaction (PCR), and sequencing technology are some of the significant technologies used for test sample preparation. Doctors and researchers have shifted their focus from traditional diagnostic methods to personalized medicines owing to continuous innovation in IVD product design and technologies.

The rise in incidences of chronic & infectious diseases along with growth in aging population subjected to immunological disorders have led to increasing need of IVD testing. Moreover, knowledge of rare diseases and increase in applications of personalized medicines supplement the growth of the IVD market. Adoption of IVD devices and reagents is rising due to increase in incidences of neurological disorders, colorectal cancer, and gynecological diseases. On the other hand, hostile reimbursement policies and strict government regulations would hinder the growth in the market. Rise in demand for technologically advanced diagnostic devices and growth in disposable income of consumers create new avenues in the industry. Moreover, technological advancements for development of high sensitivity point-of-care (POC) hematology testing would boost the market growth.

The IVD market is segmented into product type, technique, end users, application, and geography. Based on product type, the market is classified into reagents, instruments, and services & software. The technique segment is further classified into blood testing, immunodiagnostics, molecular diagnostics, clinical chemistry, tissue diagnostics, and other clinical techniques. Based on application, it is further divided into infectious diseases, cancer, cardiac diseases, immune system disorders, gastrointestinal diseases, nephrological diseases, and other indications. On the basis of end-users, it is categorized into standalone laboratory, hospitals, point of care, academics & medical schools, and others. The regional breakdown and detailed analysis of each of the aforementioned segments are included for regions namely, North America, Asia-Pacific, Europe, and LAMEA.

Key market players in the IVD market have implemented key strategies, such as product launch, expansion, and acquisition to expand their market presence. For instance, the new Cobas c513 analyzer was launched Roche Diagnostic in October 2015. HbA1c testing for risk identification, diagnosis, and monitoring of diabetic patients are benefits of it. Leading industry players have adopted acquisition of small diagnostic devices and reagents providers as their strategy to strengthen their market presence. For instance, Pall Corporation was acquired by Danaher Corporation in August 2015. This move was aimed to raise expertise of Danaher Corporation in life science and diagnostic market. Abbott, Roche diagnostics, and Danaher Corporation are some of the key companies operating in the IVD market.
Other prominent companies include Johnson and Johnson, Sysmex Corporation, Becton Dickinson, bioMrieux, Siemens AGand Alere Inc., Thermo Fisher Scientific, Inc., and Ortho-Clinical Diagnostics. Comprehensive competitive analysis and profiles of key market players mentioned above are offered in the report.

KEY BENEFITS FOR STAKEHOLDERS:
  • This report offers a comprehensive analysis of the current trends and changing dynamics in the world IVD market.
  • Geographically, the world IVD market is segmented into North America, Europe, Asia-Pacific and LAMEA.
  • This report offers an in-depth quantitative analysis of the current market and estimations from 2016 to 2025 to assist in identification of market opportunities.
  • Extensive analysis of the world IVD market based on techniques helps in understanding various IVD testing techniques which will gain popularity in the future.
  • Competitive scenario highlights the business practices adopted by leading market players across different geographies.

Chapter: 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1 CXO perspective
2.2 Market beyond: what to expect by 2027

2.2.1 Base case scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario

Chapter: 3 WORLD IVD MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top impacting factors
3.2.2 Top investment pockets
3.2.3 Top winning strategies

3.3 Porter five forces analysis

3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Low threat of new entrants
3.3.4 Threat of substitute
3.3.5 Competitive rivalry

3.4 Government regulations
3.5 Value chain analysis
3.6 Market share analysis, 2014
3.7 Market player positioning, 2015
3.8 Case studies

3.8.1 Case Study 1: Positioning of new IVD Platform by Life Science
3.8.2 Case Study 2: To enhance the operational capabilities of diagnostic chemistry system

3.9 Research & Analysis

3.9.1 Clinical Trials of research studies conducted for IVD market

3.10 Significant Progressions in IVD technologies

3.10.1 Total Laboratory Automation (TLA)
3.10.2 Evolving markets in digital pathology
3.10.3 Omics and Genetics tests in IVD
3.10.4 Point-of-Care testing
3.10.5 Emerging technologies diagnostics and influence on IVD

3.11 Market dynamics

3.11.1 Drivers

3.11.1.1 Increasing incidences of chronic and infectious diseases
3.11.1.2 Technological advancements in IVD
3.11.1.3 Emergence of minimal invasive technologies
3.11.1.4 Increasing government expenditures on healthcare
3.11.1.5 Increase in popularity personalized medicine approach

3.11.2 Restraints

3.11.2.1 Unclear reimbursement policies
3.11.2.2 Stringent Regulatory policies

3.11.3 Opportunities

3.11.3.1 Potential Opportunities for outsourcing
3.11.3.2 Convergence of new Technologies.

Chapter: 4 MARKETBY PRODUCT TYPE, 2015-2022

4.1 Overview

4.1.1 Market size and forecast

4.2 Reagents

4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast

4.3 Instruments

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast

4.4 Software and services

4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast

Chapter: 5 MARKETBY TECHNIQUES, 2015-2022

5.1 Overview

5.1.1 Market size and forecast

5.2 Immunodiagnostics

5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast
5.2.4 Enzyme-Linked Immunosorbent Assay (ELISA)

5.2.4.1 Market size and forecast
5.2.4.2 Chemiluminescence Immunoassay (CLIA)

5.2.4.2.1 MARKET SIZE AND FORECAST

5.2.4.3 Fluorescence immunoassay (FIA)

5.2.4.3.1 MARKET SIZE AND FORECAST

5.2.4.4 Colorimetric Immunoassay (CI)

5.2.4.4.1 MARKET SIZE AND FORECAST

5.2.5 Rapid Tests

5.2.5.1 Market size and forecast

5.2.6 Enzyme-Linked ImmunoSpot (ELISPOT)

5.2.6.1 Market size and forecast

5.2.7 Radioimmunoassay (RIA)

5.2.7.1 Market size and forecast

5.2.8 Western blot

5.2.8.1 Market size and forecast

5.3 Blood testing

5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast

5.4 Molecular diagnostics

5.4.1 Key market trends
5.4.2 Key growth factors and opportunities
5.4.3 Market size and forecast
5.4.4 Polymerize Chain Reaction (PCR)

5.4.4.1 Market size and forecast

5.4.5 Isothermal Nucleic Acid Technology (INAAT)

5.4.5.1 Market size and forecast

5.4.6 Hybridization

5.4.6.1 Market size and forecast

5.4.7 DNA diagnostics

5.4.7.1 Market size and forecast

5.4.8 Microarray

5.4.8.1 Market size and forecast

5.4.9 Others

5.4.9.1 Market size and forecast

5.5 Tissue diagnostics

5.5.1 Key market trends
5.5.2 Key growth factors and opportunities
5.5.3 Market size and forecast

5.6 Clinical chemistry

5.6.1 Key market trends
5.6.2 Key growth factors and opportunities
5.6.3 Market size and forecast
5.6.4 Basic metabolic panel

5.6.4.1 Market size and forecast

5.6.5 Liver panel

5.6.5.1 Market size and forecast

5.6.6 Renal profile

5.6.6.1 Market size and forecast

5.6.7 Lipid profile

5.6.7.1 Market size and forecast

5.6.8 Thyroid function panel

5.6.8.1 Market size and forecast

5.6.9 Electrolyte panel

5.6.9.1 Market size and forecast

5.6.10 Speciality chemicals

5.6.10.1 Market size and forecast

5.7 Other IVD techniques

5.7.1 Key market trends
5.7.2 Key growth factors and opportunities
5.7.3 Market size and forecast

Chapter: 6 MARKETBY INDICATION, 2015-2022

6.1 Overview

6.1.1 Market size and forecast

6.2 Infectious diseases

6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast

6.3 Cancer

6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast

6.4 Cardiac diseases

6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast

6.5 Immune system diseases

6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast

6.6 Nephrological diseases

6.6.1 Key market trends
6.6.2 Key growth factors and opportunities
6.6.3 Market size and forecast

6.7 Gastrointestinal diseases

6.7.1 Key market trends
6.7.2 Key growth factors and opportunities
6.7.3 Market size and forecast

6.8 Other indications

6.8.1 Key market trends
6.8.2Key growth factors and opportunities
6.8.3Market size and forecast

Chapter: 7 MARKET BY END USERS, 2015-2022

7.1 Overview

7.1.1 Market size and forecast

7.2 Standalone laboratories

7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast

7.3 Hospitals

7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast

7.4 Academic and Medical schools

7.4.1 Key market trends
7.4.2 Key growth factors and opportunities
7.4.3 Market size and forecast

7.5 Point of care testing

7.5.1 Key market trends
7.5.2 Growth factors and opportunities
7.5.3 Market size and forecast

7.6 Others

7.6.1 Key market trends
7.6.2 Key growth factors and opportunities
7.6.3 Market size and forecast

Chapter: 8 MARKET BY GEOGRAPHY, 2015-2022

8.1 Overview

8.1.1 Market size and forecast

8.2 North America

8.2.1 Key market trends
8.2.2 Key growth factors and opportunities
8.2.3 Market size and forecast
8.2.4 United states

8.2.4.1 Market size and forecast

8.2.5 Canada

8.2.5.1 Market size and forecast

8.2.6 Mexico

8.2.6.1 Market size and forecast

8.3 Europe

8.3.1 Key market trends
8.3.2 Key growth factors and opportunities
8.3.3 Market size and forecast
8.3.4 Germany

8.3.4.1 Market size and forecast

8.3.5 France

8.3.5.1 Market size and forecast

8.3.6 United Kingdom

8.3.6.1 Market size and forecast

8.3.7 Others

8.3.7.1 Market size and forecast

8.4 Asia Pacific

8.4.1 Key market trends
8.4.2 Key growth factors and opportunities
8.4.3 Market size and forecast
8.4.4 India

8.4.4.1 Market size and forecast

8.4.5 China

8.4.5.1 Market size and forecast

8.4.6 Japan

8.4.6.1 Market size and forecast

8.4.7 Australia

8.4.7.1 Market size and forecast

8.4.8 Others

8.4.8.1 Market size and forecast

8.5 LAMEA

8.5.1 Key market trends
8.5.2 Key growth factors and opportunities
8.5.3 Market size and forecast
8.5.4 Latin America

8.5.4.1 Market size and forecast

8.5.5 Middle East

8.5.5.1 Market size and forecast

8.5.6 Africa

8.5.6.1 Market size and forecast

Chapter: 9 COMPANY PROFILES

9.1 Affymetrix Inc.

9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Financial performance of Affymetrix Inc.
9.1.4 Key Strategies and development
9.1.5 SWOT analysis of Affymetrix

9.2 Alere Inc.

9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Business performance
9.2.4 Key strategies and developments
9.2.5 SWOT analysis of Alere

9.3 Biomerieux

9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Business performance
9.3.4 Key strategies and developments
9.3.5 SWOT analysis of BioMerieux

9.4 Danaher Corporation.

9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Business performance
9.4.4 Key strategies and development
9.4.5 SWOT analysis of Danaher Corporation

9.5 Roche Diagnostics

9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Business performance
9.5.4 Key strategies and developments
9.5.5 SWOT analysis of Roche Diagnostics

9.6 Becton Dickinson and Company

9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Business performance
9.6.4 Key strategies and development
9.6.5 SWOT analysis of Becton Dickinson and Company

9.7 Bio-Rad Laboratories, Inc.

9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Business performance
9.7.4 Key strategies and developments
9.7.5 SWOT analysis of Bio-Rad Laboratories, Inc.

9.8 Abbott Laboratories

9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Business performance
9.8.4 Key strategies and developments
9.8.5 SWOT analysis of Abbott Laboratories

9.9 Bayer AG.

9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Business performance
9.9.4 Key strategies and development
9.9.5 SWOT analysis of Bayer AG

9.10 Arkray, Inc.

9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Key strategies and development
9.10.4 SWOT analysis of Arkray, Inc.

9.11 Sysmex Corporation

9.11.1 Company overview
9.11.2 Company snapshot
9.11.3 Business performance
9.11.4 Key strategies and developments
9.11.5 SWOT analysis of Sysmex Corporation

9.12 Johnson & Johnson Pvt Ltd.

9.12.1 Company overview
9.12.2 Company snapshot
9.12.3 Business performance
9.12.4 Key strategies and development
9.12.5 SWOT analysis of Johnson & Johnson Pvt Ltd.

9.13 Siemens AG

9.13.1 Company overview
9.13.2 Company snapshot
9.13.3 Business performance
9.13.4 Key strategies and development
9.13.5 SWOT analysis of Siemens AG

List of Table

TABLE 1 WORLD IVD BASE CASE SCENARIO MARKET, BY GEOGRAPHY, 2022 2027 ($MILLION)
TABLE 2 WORLD IVD RAPID GROWTH SCENARIO MARKET, BY GEOGRAPHY, 2022 2027 ($MILLION)
TABLE 3 WORLD IVD DIMINISHING GROWTH SCENARIO MARKET, BY GEOGRAPHY, 2022 2027 ($MILLION)
TABLE 4 PORTERS FIVE FORCES ANALYSIS
TABLE 5 MARKET SHARE AND REVENUE OF CRPC DRUG INNOVATORS
TABLE 6 CLINICAL TRIALS - IN VITRO DIAGNOSTIC DEVICES
TABLE 7 GLOBAL INCIDENCES OF DISEASES
TABLE 8 MARKETBY PRODUCT TYPE, 2015-2022 ($MILLION)
TABLE 9 MARKETBY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 10 WORLD IVD REAGENTS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 11 WORLD IVD INSTRUMENTS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 12 WORLD IVD SOFTWARE AND SERVICES MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 13 MARKET BY TECHNIQUE, 2015-2022 ($MILLION)
TABLE 14 WORLD IMMUNODIAGNOSTIC TECHNIQUE MARKET, BY TECHNIQUES, 2015-2022 ($MILLION)
TABLE 15 WORLD IMMUNODIAGNOSTIC TECHNIQUE MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 16 WORLD ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) MARKET, 2015-2022 ($MILLION)
TABLE 17 WORLD BLOOD TESTING MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 18 WORLD MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2015-2022 ($MILLION)
TABLE 19 WORLD MOLECULAR DIAGNOSTICS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 20 WORLD TISSUE DIAGNOSTICS TECHNIQUE MARKET, 2015-2022, ($MILLION)
TABLE 21 WORLD CLINICAL CHEMISTRY TECHNIQUE MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 22 WORLD OTHER CLINICAL TECHNIQUES MARKET, BY GEOGRAPHY, 2015-2022, ($MILLION)
TABLE 23 WORLD IVD MARKET, BY INDICATION, 2015-2022 ($MILLION)
TABLE 24 WORLD IVD INFECTIOUS DISEASES MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 25 WORLD IVD CANCER MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 26 WORLD IVD CARDIAC DISEASES MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 27 WORLD IVD IMMUNE SYSTEM DISORDER MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 28 WORLD IVD NEPHROLOGICAL DISEASES MARKET, BY GEOGRAPHY, 2015-2022, ($MILLION)
TABLE 29 WORLD IVD GASTRINTESTINAL DISEASES MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 30 WORLD IVD OTHER INDICATION MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 31 MARKETBY END USER, 2015-2022, ($MILLION)
TABLE 32 WORLD IVD STANDALONE LABORATORIES MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 33 WORLD IVD HOSPITALS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 34 WORLD IVD ACADEMIC AND MEDICAL SCHOOLS MARKET, BY GEOGRAPHY, 2015- 2022 ($MILLION)
TABLE 35 WORLD IVD POINT OF CARE TESTING MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 36 WORLD IVD OTHERS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 37 WORLD IVD MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 38 NORTH AMERICA IVD MARKET, BY TECHNIQUES, 2015-2022 ($MILLION)
TABLE 39 UNITED STATES IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 40 CANADA IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 41 MEXICO IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 42 EUROPE IVD MARKET, BY TECHNIQUES, 2015-2022 ($MILLION)
TABLE 43 GERMANY IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 44 FRANCE IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 45 UNITED KINGDOM IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 46 OTHERS EUROPEAN IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 47 ASIA PACIFIC IVD MARKET, BY TECHNIQUES, 2015-2022 ($MILLION)
TABLE 48 INDIA IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 49 CHINA IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 50 JAPAN IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 51 CATEGORIZATION OF IVD DEVICES
TABLE 52 AUSTRALIA IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 53 OTHERS IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 54 LAMEA IVD MARKET, BY TECHNIQUES, 2015-2022 ($MILLION)
TABLE 55 LATIN AMERICA IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 56 MIDDLE EAST IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 57 AFRICA IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 58 COMPANY SNAPSHOT OF AFFYMETRIX INC.
TABLE 59 ALERE INC. COMPANY SNAPSHOT
TABLE 60 BIOMERIEUX COMPANY SNAPSHOT
TABLE 61 DANAHER CORPORATION COMPANY SNAPSHOT
TABLE 62 ROCHE DIAGNOSTICS COMPANY SNAPSHOT
TABLE 63 BECTON DICKINSON AND COMPANY SNAPSHOT
TABLE 64 BIO-RAD LABORATORIES, INC. COMAPNY SNAPSHOT
TABLE 65 ABBOTT LABORATORIES SNAPSHOT
TABLE 66 BAYER AG COMPANY SNAPSHOT
TABLE 67 ARKRAY, INC. COMPANY SNAPSHOT
TABLE 68 SYSMEX CORPORATION COMPANY SNAPSHOT
TABLE 69 JOHNSON & JOHNSON PVT LTD. COMPANY SNAPSHOT
TABLE 70 SIEMENS AGCOMPANY SNAPSHOT

List of Figures

FIG. 1 WORLD IVD MARKET SNAPSHOT
FIG. 1 TOP IMPACTING FACTORS, BASE CASE SCENARIO (2022-2027)
FIG. 2 TOP IMPACTING FACTORS, RAPID GROWTH SCENARIO (2022-2027)
FIG. 3 TOP IMPACTING FACTORS, DIMINISHING GROWTH SCENARIO (2022-2027)
FIG. 4 TOP IMPACTING FACTORS
FIG. 5 TOP INVESTMENT POCKETS OF IVD MARKET BY TECHNIQUES 2015-2022.
FIG. 6 TOP WINNING STRATEGIES
FIG. 7 TOP WINNING STRATEGIES
FIG. 8 VALUE CHAIN ANALYSIS FOR IVD MARKET
FIG. 9 MARKET SHARE OF KEY PLAYERS IN IVD MARKET
FIG. 10 MARKET PLAYER POSITIONING, 2014
FIG. 11 WORLD CHEMILUMINESCENCE IMMUNOASSAY (CLISA) MARKET, 2015-2022 ($MILLION)
FIG. 12 WORLD FLUORESCENCE IMMUNOASSAY (FIA) MARKET, 2015-2022 ($MILLION)
FIG. 13 WORLD COLORIMETRIC IMMUNOASSAY (CI) MARKET, 2015-2022 ($MILLION)
FIG. 14 WORLD RAPID TESTS MARKET, 2015-2022 ($MILLION)
FIG. 15 WORLD ENZYME-LINKED IMMUNOSPOT (ELISPOT) MARKET, 2015-2022 ($MILLION)
FIG. 16 WORLD RADIOIMMUNOASSAY (RIA) MARKET, 2015-2022 ($MILLION)
FIG. 17 WORLD WESTERN BLOT TECHNIQUE MARKET, 2015-2022 ($MILLION)
FIG. 18 WORLD POLYMERIZE CHAIN REACTION PCR MARKET, 2015-2022 ($MILLION)
FIG. 19 WORLD ISOTHERMAL NUCLEIC ACID TECHNOLOGY (INAAT) MARKET, 2015-2022 ($MILLION)
FIG. 20 WORLD HYBRIDIZATION MARKET, 2015-2022 ($MILLION)
FIG. 21 WORLD DNA DIAGNOSTICS MARKET, 2015-2022 ($MILLION)
FIG. 22 WORLD MICROARRAY MARKET, 2015-2022 ($MILLION)
FIG. 23 WORLD OTHER MOLECULAR DIAGNOSTIC MARKET, 2015-2022 ($MILLION)
FIG. 24 WORLD BASIC METABOLIC PANEL MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
FIG. 25 WORLD LIVER PANEL MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
FIG. 26 WORLD RENAL PROFILE MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
FIG. 27 WORLD LIPID PANEL MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
FIG. 28 WORLD THYROID FUNCTION PANEL MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
FIG. 29 WORLD ELECTROLYTE PANEL MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
FIG. 30 WORLD SPECIALITY CHEMICALS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
FIG. 31 KEY FINANCIALS OF AFFYMETRIX INC. REVENUE, 2012-2014, $MILLION
FIG. 32 KEY FINANCIALS OF AFFYMETRIX INC. REVENUE BY SEGMENTS
FIG. 33 KEY FINANCIALS OF AFFYMETRIX INC.CORPORATION REVENUE BY GEOGRAPHY
FIG. 34 SWOT ANALYSIS OF AFFYMETRIX INC.
FIG. 35 KEY FINANCIALS OF ALERE INC. REVENUE, 2012-2014, $MILLION
FIG. 36 ALERE INC., % NET SALES BY BUSINESS SEGMENTS, 2014
FIG. 37 ALERE INC., % NET SALES BY GEOGRAPHY, 2014
FIG. 38 SWOT ANALYSIS OF ALERE INC.
FIG. 39 KEY FINANCIALS OF BIOMERIEUX REVENUE, 2011-2014, $MILLION
FIG. 40 BIOMERIEUX, % NET SALES BY TECHNOLOGY, 2014
FIG. 41 BIOMERIEUX, % NET SALES BY GEOGRAPHY, 2014
FIG. 42 SWOT ANALYSIS OF BIOMERIEUX
FIG. 43 DANAHER CORPORATION, % NET SALES BY BUSINESS SEGMENT, 2014
FIG. 44 DANAHER CORPORATION, % NET SALES BY GEOGRAPHY, 2014
FIG. 45 SWOT ANALYSIS OF DANAHER CORPORATION
FIG. 46 KEY FINANCIALS OF ROCHE DIAGNOSTICS REVENUE, 2012-2014, $MILLION
FIG. 47 ROCHE DIAGNOSTICS, % NET SALES BY BUSINESS SEGMENT, 2014
FIG. 48 ROCHE DIAGNOSTICS, % NET SALES BY GEOGRAPHY, 2014
FIG. 49 SWOT ANALYSIS OF ROCHE DIAGNOSTICS
FIG. 50 KEY FINANCIALS OF BECTON, DICKINSON AND COMPANY REVENUE, 2011-2014, $MILLION
FIG. 51 KEY FINANCIALS OF BECTON DICKINSON AND COMPANY REVENUES BY SEGMENT 2014
FIG. 52 KEY FINANCIALS OF BECTON DICKINSON AND COMPANY SALES BY GEOGRAPHY 2014
FIG. 53 SWOT ANALYSIS OF BECTON DICKINSON AND COMPANY
FIG. 54 KEY FINANCIALS OF BIO-RAD LABORATORIES REVENUE, 2012-2014, $MILLION
FIG. 55 BIO RAD LABORATORIES, INC., % REVENUE BY BUSINESS SEGMENT, 2014
FIG. 56 BIO RAD LABORATORIES, INC., % REVENUE BY GEOGRAPHY, 2014
FIG. 57 SWOT ANALYSIS OF BIO-RAD LABORATORIES, INC.
FIG. 58 KEY FINANCIALS OF ABBOTT LABORATORIES REVENUE, 2012-2014, $MILLION
FIG. 59 ABBOTT LABORATORIES, INC., % REVENUE BY BUSINESS SEGMENT, 2014
FIG. 60 ABBOTT LABORATORIES, INC., % REVENUE BY GEOGRAPHY, 2014
FIG. 61 SWOT ANALYSIS OF ABBOTT LABORATORIES
FIG. 62 KEY FINANCIALS OF ABBOTT LABORATORIES REVENUE, 2012-2014, $MILLION
FIG. 63 BAYER AG, % REVENUE BY BUSINESS SEGMENT, 2014
FIG. 64 SWOT ANALYSIS OF BAYER AG
FIG. 65 SWOT ANALYSIS OF ARKRAY, INC.
FIG. 66 KEY FINANCIALS OF SYSMEX CORPORATION REVENUE, 2012-2014, $MILLION
FIG. 67 SYSMEX CORPORATION, % REVENUE, BY BUSINESS SEGMENT, 2014
FIG. 68 SYSMEX CORPORATION, % REVENUE, BY PRODUCT TYPE, 2014
FIG. 69 SYSMEX CORPORATION, % REVENUE BY GEOGRAPHY, (2014)
FIG. 70 SWOT ANALYSIS OF SYSMEX CORPORATION
FIG. 71 KEY FINANCIALS OF JOHNSON & JOHSNON $MILLION (2012-2014)
FIG. 72 FINANCIAL REVENUES BY SEGMENTS (2014)
FIG. 73 FINANCIAL REVENUES BY GEOGRAPHY (2014)
FIG. 74 SWOT ANALYSIS OF JOHNSON & JOHNSON PVT LTD.
FIG. 75 SIEMENS AG., % REVENUE BY BUSINESS SEGMENT, 2014
FIG. 76 SIEMENS AG., % REVENUE BY GEOGRAPHY, 2014
FIG. 77 SWOT ANALYSIS OF SIEMENS AG

License Type
Single User PDF
Enterprise Online /PDF
Price
User / Sharing
Restricted to one authorized user
Unlimited within company / enterprise
Printing
One Print only
Unlimited within company / enterprise
Delivery Formats
ADDED BENIFITS

20% Free customization (Pre-sale)

16 Analyst hour support (Post Sale)

40 Analyst hour support (Post Sale)

160 hours of mini-consult

Free quarterly industry update

Free report on update (within 180 days)

MULTIPLE PURCHASE

Complimentary report with 2 reports

Complimentary report with 3 reports

Subscription Model

 
 

Similar Market Research Report

blog
Dec
2017
Blockchain Distributed Ledger Market

Progressive Markets added a report, Blockchain Distributed Ledger Market - Size, Trend, Share, Opportunity Analysis, and Forecast, 2014-2025, which says that the global blockchain distributed ledger market is likely to grow at a CAGR of 55.69% from 2018 to 2025. Read More >>

 

Get Email Alert